Abiopharma

🔍 Jin David (Executive)

Company: Fortress Biotech, Inc. (FBIO)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 2,967 shares of Common Stock, par value $0.001 at $2.176 per share (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,251,571.00 | transaction_form_type: 5 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
• F2: Total holdings include 1,230,000 shares underlying deferred restricted stock units.